Since the regulation of tumor-associated signaling pathways by KLF5 is USP38-dependent, USP38 becomes a potential therapeutic target for lung adenocarcinoma, providing a new direction for the precise treatment of lung adenocarcinoma. The gene discussed is KLF5; the disease is neoplasm.